SPX4,140.06-5.13 -0.12%
DIA328.42+0.45 0.14%
IXIC12,644.46-13.10 -0.10%

BRIEF-Greenwich LifeSciences Provides Financing Strategy & Corporate Update

BRIEF-Greenwich LifeSciences Provides Financing Strategy & Corporate Update

Reuters · 07/28/2022 06:03
BRIEF-Greenwich LifeSciences Provides Financing Strategy & Corporate Update

- Greenwich Lifesciences Inc GLSI:

  • GREENWICH LIFESCIENCES - BELIEVE CO IS WELL CAPITALIZED WITH CASH BALANCE REPORTED ON CO'S FORM 10-Q FOR PERIOD ENDING MARCH 31, 2022 OF $19.7 MILLION

  • GREENWICH LIFESCIENCES INC - COMMENCEMENT OF PHASE III CLINICAL TRIAL, FLAMINGO-01, IS EXPECTED TO INCREASE BURN RATE GRADUALLY OVER TIME

  • GREENWICH LIFESCIENCES INC - INTEND TO USE ATM FACILITY OPPORTUNISTICALLY IN FUTURE AND DO NOT PRESENTLY INTEND TO USE FULL AMOUNT OF ATM FACILITY

  • GREENWICH LIFESCIENCES INC - AN UPDATE ON FLAMINGO-01 TRIAL IS EXPECTED TO BE PROVIDED SHORTLY

Source text for Eikon: ID:

Further company coverage: GLSI


((Reuters.Briefs@thomsonreuters.com;))